Discover Our Unique Cartilage Repair Solution

Our injectable solution consists, via cellular therapy, in repairing in a solid and lasting way the lesions of the cartilage which have occurred following a trauma or a degenerative disease such as osteoarthritis or osteochondritis dissecans.

Our strategy is to combine the properties of a chitosan hydrogel environment (natural, biodegradable and biocompatible polymer) with perfectly controlled cartilage cells. Five years were needed to create our articular cartilage gel ready for implantation, validated within the framework of a research program with the CNRS. Animal testing performed by an international CRO (contract research organization) has confirmed the adherence, safety and efficacy of our solution. This innovation has been protected by a portfolio of 9 patents since 2014.

We want to offer patients an innovative, reliable and long-lasting solution with only one injection by minimally invasive surgery. We work on state-of-the-art technology to effectively and permanently combat tissue degeneration and pain .

In 2017, our first crowdfunding campaign led us to the validation of our product within the framework of regulatory in vivo pre-clinical tests . Thanks to you, contributors and investors, as well as the support of banks and the European community (Eurostars winner), we have continued to develop our unique cartilage repair solution.

ACS Biotech opens its capital again, join us!
A few weeks ago, we launched a new crowdfunding campaign on the Happy Capital platform.

Become an actor of medical progress and contribute to the launch of our first clinical study with a view to repairing cartilage lesions .